Sun, Jan 25, 2015, 6:25 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Eli Lilly and Company Message Board

  • jeneymic jeneymic Aug 13, 2013 8:34 AM Flag

    AMBS--Alzheimer blood test on board and now News of MANF for Retinosa Pigmentosa...Big stuff.

    Heading north. OTCB...not for long.
    Over the past several months, we've been following the emerging story at Amarantus BioScience Holdings, Inc. (AMBS.OB). Much of our interest in the story is based upon LymPro, the company's Alzheimer's Disease Blood Test based on Lymphocyte Proliferation. However, on August 12, 2013, Amarantus announced preclinical data with its therapeutic candidate, MANF, for the treatment of Retinitis Pigmentosa (RP). The idea of utility for MANF in this indication is interesting because RP qualifies as a potential orphan disease.

72.13-0.33(-0.46%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.